Manufacturing roundup: Aspen teams up with the Serum Institute; Porton secures several strategic partnerships
While South African-based manufacturer Aspen looks at a possible change in direction for producing Covid-19 vaccines for the African continent, the company has secured a new contract with a major vaccine player.
The Serum Institute of India and Aspen have entered into a 10-year agreement, in which Aspen will manufacture and distribute four of its vaccines for the African market, with some of those vaccines being available for The Serum Institute to also distribute on the continent.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters